Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rhythm Pharmaceuticals (RYTM) Cash from Investing Activities (2016 - 2025)

Rhythm Pharmaceuticals (RYTM) has disclosed Cash from Investing Activities for 10 consecutive years, with $30.3 million as the latest value for Q4 2025.

  • Quarterly Cash from Investing Activities rose 43.44% to $30.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$137.2 million through Dec 2025, down 184.71% year-over-year, with the annual reading at -$137.2 million for FY2025, 184.71% down from the prior year.
  • Cash from Investing Activities for Q4 2025 was $30.3 million at Rhythm Pharmaceuticals, up from -$246.3 million in the prior quarter.
  • The five-year high for Cash from Investing Activities was $72.5 million in Q1 2022, with the low at -$246.3 million in Q3 2025.
  • Average Cash from Investing Activities over 5 years is -$11.3 million, with a median of $19.8 million recorded in 2023.
  • The sharpest move saw Cash from Investing Activities plummeted 662.57% in 2022, then skyrocketed 731.1% in 2025.
  • Over 5 years, Cash from Investing Activities stood at $7.2 million in 2021, then tumbled by 662.57% to -$40.8 million in 2022, then soared by 155.52% to $22.6 million in 2023, then decreased by 6.55% to $21.2 million in 2024, then skyrocketed by 43.44% to $30.3 million in 2025.
  • According to Business Quant data, Cash from Investing Activities over the past three periods came in at $30.3 million, -$246.3 million, and $54.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.